The predictive value of cardiorespiratory fitness combined with coronary risk evaluation and the risk of cardiovascular and all‐cause death
Open Access
- 13 April 2007
- journal article
- Published by Wiley in Journal of Internal Medicine
- Vol. 262 (2) , 263-272
- https://doi.org/10.1111/j.1365-2796.2007.01807.x
Abstract
Background. There are no data on directly measured cardiorespiratory fitness combined coronary risk evaluation with respect to death from cardiovascular diseases and all‐causes. We investigated the prognostic significance of risk scores and cardiorespiratory fitness with respect to cardiovascular disease and all‐cause mortality. Methods. Cardiorespiratory fitness (maximal oxygen uptake, VO2peak) was measured by exercise test with an electrically braked cycle ergometer. The study is based on a random population‐based sample of 1639 men (42–60 years) without history of type 2 diabetes or atherosclerotic cardiovascular diseases. Results. During an average follow‐up of 16 years, a total of 304 deaths occurred. Independent predictors for all‐cause death were European Score (for 1% increment, RR 1.15, 95% CI 1.10–1.20), VO2peak (for 1 MET increment, RR 0.84, 95% CI 0.78–0.89), when adjusted for C‐reactive protein, alcohol consumption, serum high‐density lipoprotein, waist‐to‐hip ratio, family history of coronary heart disease, exercise‐induced ST changes and the use of medications for hypertension, dyslipidaemia or aspirin. Also, Framingham risk score was related to the risk of death (RR 1.05, 95% CI 1.03–1.07, P < 0.001). Subjects with high European or Framingham score and low VO2peak represent the highest risk group. Conclusion. An important finding is that the risk scores can be used to identify men for whom low cardiorespiratory fitness predicts an especially high risk for death from cardiovascular and any other cause.Keywords
This publication has 28 references indexed in Scilit:
- Does implementation of the European guidelines based on the SCORE model double the number of Norwegian adults who need cardiovascular drugs for primary prevention? The Tromsø study 2001European Heart Journal, 2005
- Exercise Testing in Asymptomatic AdultsCirculation, 2005
- Screening with the exercise test: time for a guideline change?The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.European Heart Journal, 2005
- Cardiac Power During Exercise and the Risk of Stroke in MenStroke, 2005
- Usefulness of Exercise Testing in the Prediction of Coronary Disease Risk Among Asymptomatic Persons as a Function of the Framingham Risk ScoreCirculation, 2004
- The predictive value of cardiorespiratory fitness for cardiovascular events in men with various risk profiles: a prospective population-based cohort studyEuropean Heart Journal, 2004
- Exercise Capacity and the Risk of Death in WomenCirculation, 2003
- Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE projectPublished by Oxford University Press (OUP) ,2003
- American College of Cardiology/American Heart Association clinical competence statement on stress testing: A report of the American College of Cardiology/American Heart Association/American College of Physicians–American Society of Internal Medicine Task Force on Clinical CompetencePublished by Elsevier ,2000
- Prognostic significance of peak exercise capacity in patients with coronary artery diseaseJournal of the American College of Cardiology, 1994